2 completed, 1 unknown. 2 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow COVID Convalescent Plasma: new trials by email Literature Review of COVID Convalescent Plasma trials Research Report on COVID Convalescent Plasma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID-19 in Adult Recipients Following Hematopoietic Stem Cell Transplantation COVID Convalescent Plasma - COVID-19, Hematopoietic Stem Cell Transplantation | Not applicable | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 72 | 2023-06-10 | 2023-06-15 |
| Assessment of Safety and Efficacy of CCP COVID Convalescent Plasma - Covid19 | Not applicable | Completed | Makerere University | 136 | 2020-06-16 | 2021-01-15 |
| COVID-19 Convalescent Plasma (CCP) Transfusion COVID Convalescent Plasma - COVID-19 | Early Phase 1 | Completed | Gailen D. Marshall Jr., MD PhD | 86 | 2020-06-01 | 2023-11-29 |
COVID-19 (3) · Coronavirus Infections (1)
Gailen D. Marshall Jr., MD PhD (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Makerere University (1)
China (1) · Uganda (1) · United States (1)
Gailen D Marshall, Jr., MD, PhD (1)